A major European event at the heart of bioprocessing innovation BioProcess International Europe (BPI Europe) will take place on April 29–30, 2026, at the VIECON – Vienna Congress & Convention…
iPSC endothelial disease models are emerging as powerful tools to study vascular disorders and enable predictive, patient-specific therapeutic strategies. The advent of induced pluripotent stem cell (iPSC) technology has fundamentally…
The increasing failure rate of anticancer therapies during clinical translation highlights a fundamental limitation of conventional preclinical models. While two-dimensional (2D) cell cultures have historically supported drug discovery pipelines, they…
3D cell culture cancer models are increasingly recognized as essential tools to understand chemotherapy resistance and tumor behavior. In vitro cancer research has long relied on two-dimensional (2D) cell culture…
Cellura will participate in the upcoming PSCC Ecosystem Breakfast in Paris Saclay, where Benjamin Saulnier, CEO of Cellura, will present SoftXS™ as a breakthrough technology designed to address one of…
